Jacques Rouanet (J Rouanet)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Prognostic Factors

Basal Cell Carcinoma

Top Venues

Journal of the European Academy of Dermatology and Venereology : JEADV

Cancer immunology, immunotherapy : CII

This page only lists publications with an associated author ORCID identifier.

Publications

Didier Bessis, Anne-Claire Bursztejn, Fanny Morice-Picard, Yline Capri, Sébastien Barbarot, Hélène Aubert, Damien Bodet, Emmanuelle Bourrat, Christine Chiaverini, Laura Poujade, Marjolaine Willems, Jacques Rouanet, Anne Dompmartin-Blanchère, David Geneviève, Marion Gerard, Emmanuelle Ginglinger, Smail Hadj Rabia, Ludovic Martin, Juliette Mazereeuw-Hautier, Nathalie Bibas, Nicolas Molinari, Fanchon Herman, Alice Phan, Julien Rod, Hugues Roger, Sabine Sigaudy, Alban Ziegler, Yoann Vial, Alain Verloes, Hélène Cave, Didier Lacombe
Dermatological manifestations in Costello syndrome: A prospective multicentric study of 31 HRAS-positive variant patients. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Didier Bessis, Anne-Claire Bursztejn, Fanny Morice-Picard, Yline Capri, Sébastien Barbarot, Hélène Aubert, Damien Bodet, Emmanuelle Bourrat, Christine Chiaverini, Laura Poujade, Marjolaine Willems, Jacques Rouanet, Anne Dompmartin-Blanchère, David Geneviève, Marion Gerard, Emmanuelle Ginglinger, Smail Hadj Rabia, Ludovic Martin, Juliette Mazereeuw-Hautier, Nathalie Bibas, Nicolas Molinari, Fanchon Herman, Alice Phan, Julien Rod, Hugues Roger, Sabine Sigaudy, Alban Ziegler, Yoann Vial, Alain Verloes, Hélène Cave, Didier Lacombe
Dermatological manifestations in Costello syndrome: A prospective multicentric study of 31 HRAS-positive variant patients. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (9) (2024)
Didier Bessis, Anne-Claire Bursztejn, Fanny Morice-Picard, Yline Capri, Sébastien Barbarot, Hélène Aubert, Damien Bodet, Emmanuelle Bourrat, Christine Chiaverini, Laura Poujade, Marjolaine Willems, Jacques Rouanet, Anne Dompmartin-Blanchère, David Geneviève, Marion Gerard, Emmanuelle Ginglinger, Smail Hadj Rabia, Ludovic Martin, Juliette Mazereeuw-Hautier, Nathalie Bibas, Nicolas Molinari, Fanchon Herman, Alice Phan, Julien Rod, Hugues Roger, Sabine Sigaudy, Alban Ziegler, Yoann Vial, Alain Verloes, Hélène Cave, Didier Lacombe
Dermatological manifestations in Costello syndrome: A prospective multicentric study of 31 HRAS-positive variant patients. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (9) (2024)
Charlée Nardin, Aymeric Hennemann, Kadiatou Diallo, Elisa Funck-Brentano, Eve Puzenat, Valentine Heidelberger, Géraldine Jeudy, Mahtab Samimi, Candice Lesage, Lise Boussemart, Lucie Peuvrel, Jacques Rouanet, Florence Brunet-Possenti, Emilie Gerard, Alice Seris, Thomas Jouary, Mélanie Saint-Jean, Marc Puyraveau, Philippe Saiag, François Aubin
Efficacy of Immune Checkpoint Inhibitor (ICI) Rechallenge in Advanced Melanoma Patients' Responders to a First Course of ICI: A Multicenter National Retrospective Study of the French Group of Skin Cancers (Groupe de Cancérologie Cutanée, GCC). Cancers 15 (14) (2023)
Hussein Akil, Mercedes Quintana, Jeremy H Raymond, Tommy Billoux, Valentin Benboubker, Sophie Besse, Philippe Auzeloux, Véronique Delmas, Valérie Petit, Lionel Larue, Michel D'Incan, Françoise Degoul, Jacques Rouanet
Efficacy of Targeted Radionuclide Therapy Using [131I]ICF01012 in 3D Pigmented BRAF- and NRAS-Mutant Melanoma Models and In Vivo NRAS-Mutant Melanoma. Cancers 13 (6) (2021)
Aurélie Rondon, Jacques Rouanet, Françoise Degoul
Radioimmunotherapy in Oncology: Overview of the Last Decade Clinical Trials. Cancers 13 (21) (2021)
Jacques Rouanet, E Lang, F Beltzung, B Evrard, C Henquell, I Joulie, M D'Incan
Recent outbreak of chilblain-like lesions is not directly related to SARS-CoV-2 infection. Journal of the European Academy of Dermatology and Venereology : JEADV 34 (11) (2020)
Jacques Rouanet, Valentin Benboubker, Hussein Akil, Ana Hennino, Philippe Auzeloux, Sophie Besse, Bruno Pereira, Solène Delorme, Sandrine Mansard, Michel D'Incan, Françoise Degoul, Paul-Olivier Rouzaire
Immune checkpoint inhibitors reverse tolerogenic mechanisms induced by melanoma targeted radionuclide therapy. Cancer immunology, immunotherapy : CII 69 (10) (2020)